Central blood pressure ( BP ) , an important measure of cardiovascular risk , has been shown to be effectively reduced by calcium channel blockade with amlodipine ( AML ) plus renin-angiotensin system blockade by the angiotensin-converting enzyme inhibitor , perindopril ( PER ) .